(Q38163988)

30 August 2017

1 reference

title

A review of immunomodulators and their application in veterinary medicine (English)

1 reference

30 August 2017

0 references

Mulcahy G

1

1 reference

30 August 2017

Quinn PJ

series ordinal

2

1 reference

30 August 2017

publication date

1 June 1986

1 reference

Journal of Veterinary Pharmacology and Therapeutics

30 August 2017

published in

1 reference

30 August 2017

volume

9

1 reference

30 August 2017

issue

2

1 reference

30 August 2017

page(s)

119-139

1 reference

Recent developments in immunomodulatory therapy

30 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1986.TB00022.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1986.TB00022.X

Cytotoxic T-cell activation by polyribonucleotides: DNA synthesis is not required

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1986.TB00022.X

Nonspecific resistance to bacterial infections. Enhancement by ubiquinone-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1986.TB00022.X

Immunomodulatory-antiinflammatory functions of E-type prostaglandins. Minireview with emphasis on macrophage-mediated effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1986.TB00022.X

Steroid Hormone Action: Recent Advances

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1986.TB00022.X

Effects of thymosin in vitro in cancer patients and correlation with clinical course after thymosin immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1986.TB00022.X

Clinical trials with thymosin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1986.TB00022.X

Corticosteroid-Mediated Immunoregulation in Man

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1986.TB00022.X

Immunostimulation: Synthetic and Biological Modulators of Immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1986.TB00022.X

Porcine interleukin 2: parameters of production and biochemical characterization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1986.TB00022.X

beta-Endorphin enhances lymphocyte proliferative responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1986.TB00022.X

Specific Nonopiate Receptors for β-Endorphin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1986.TB00022.X

Experience gained in immunotherapy from the immunopharmacology of BCG leading to a second generation of systemic immunity adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1986.TB00022.X

High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy. A randomized double-blind comparison

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1986.TB00022.X

Selective suppression of an early step in human B cell activation by cyclosporin A

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1986.TB00022.X

Toxic Properties of a Synthetic Double-stranded RNA: Pyrogenicity of Poly I.Poly C in Rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1986.TB00022.X

10.1111/J.1365-2885.1986.TB00022.X

21 January 2018

Identifiers

DOI

1 reference

30 August 2017

1 reference